Issue 10, 2022

Lab-on-a-chip technologies for minimally invasive molecular sensing of diabetic retinopathy

Abstract

Diabetic retinopathy (DR) is the most common diabetic eye disease and the worldwide leading cause of vision loss in working-age adults. It progresses from mild to severe non-proliferative or proliferative DR based on several pathological features including the magnitude of blood–retinal barrier breakdown and neovascularization. Available pharmacological and retinal laser photocoagulation interventions are mostly applied in the advanced stages of DR and are inefficient in halting disease progression in a significantly high percentage of patients. Yet, recent evidence has shown that some therapies could potentially limit DR progression if applied at early stages, highlighting the importance of early disease diagnostics. In the past few decades, different imaging modalities have proved their utility for examining retinal and optic nerve changes in patients with retinal diseases. However, imaging based-methodologies solely rely on morphological examination of the retinal vascularization and are not suitable for recurrent and personalized patient evaluation. This raises the need for new technologies to enable accurate and early diagnosis of DR. In this review, we critically discuss the potential clinical benefit of minimally-invasive molecular biomarker identification and profiling of diabetic patients who are at risk of developing DR. We provide a comparative overview of conventional and recently developed lab-on-a-chip technologies for quantitative assessment of potential DR molecular biomarkers and discuss their advantages, current limitations and challenges for future practical implementation and continuous patient monitoring at the point-of-care.

Graphical abstract: Lab-on-a-chip technologies for minimally invasive molecular sensing of diabetic retinopathy

Article information

Article type
Critical Review
Submitted
17 Dec. 2021
Accepted
18 Apr. 2022
First published
29 Apr. 2022

Lab Chip, 2022,22, 1876-1889

Lab-on-a-chip technologies for minimally invasive molecular sensing of diabetic retinopathy

M. Vieira, R. Fernandes, A. F. Ambrósio, V. Cardoso, M. Carvalho, P. Weng Kung, M. A. D. Neves and I. Mendes Pinto, Lab Chip, 2022, 22, 1876 DOI: 10.1039/D1LC01138C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements